will consumer-driven health care improve the value of health insurance benefits?

8
© 2002 Mercer Human Resource Consulting Arnold Milstein MD, MPH National Health Care Thought Leader, Mercer Medical Director, Pacific Business Group on Health [email protected] Will Consumer-Driven Health Care Improve the Value of Health Insurance Benefits? September 24, 2002

Upload: leanna

Post on 06-Jan-2016

17 views

Category:

Documents


1 download

DESCRIPTION

September 24, 2002. Will Consumer-Driven Health Care Improve the Value of Health Insurance Benefits?. Arnold Milstein MD, MPH National Health Care Thought Leader, Mercer Medical Director, Pacific Business Group on Health [email protected]. Starting Gate Observations. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Will Consumer-Driven Health Care Improve the Value of Health Insurance Benefits?

© 2002 Mercer Human Resource Consulting

Arnold Milstein MD, MPHNational Health Care Thought Leader, Mercer Medical Director, Pacific Business Group on [email protected]

Will Consumer-Driven Health Care Improve the Value ofHealth Insurance Benefits?

September 24, 2002

Page 2: Will Consumer-Driven Health Care Improve the Value of Health Insurance Benefits?

© 2002 Mercer Human Resource Consulting 2G:\HCGB\MAS\MILSTEIN\meetings\Health Policy cc 9-24-02.ppt

Starting Gate Observations

Aging and biomedical tech collide with 1.2

Purchasers seek better, less costly care

Purchasers can’t afford angry enrollees

Primary purchaser tools are incentives for consumers and suppliers

What is most likely to succeed?

Page 3: Will Consumer-Driven Health Care Improve the Value of Health Insurance Benefits?

© 2002 Mercer Human Resource Consulting 3G:\HCGB\MAS\MILSTEIN\meetings\Health Policy cc 9-24-02.ppt

#1 Focus of Incentives for Consumers

Selection of

plansAdd selection of

providers, care management,

and treatments

Focus on biggest remaining sources of total annual cost and quality variation

Page 4: Will Consumer-Driven Health Care Improve the Value of Health Insurance Benefits?

© 2002 Mercer Human Resource Consulting 4G:\HCGB\MAS\MILSTEIN\meetings\Health Policy cc 9-24-02.ppt

#2 Bases of Comparing Costliness

e.g. Pitney-Bowes, UHC, BHCAG, PBGH

Biggest discounts or lowest unit prices

Best total longitudinal efficiency

(AKA “TCO”)

Page 5: Will Consumer-Driven Health Care Improve the Value of Health Insurance Benefits?

© 2002 Mercer Human Resource Consulting 5G:\HCGB\MAS\MILSTEIN\meetings\Health Policy cc 9-24-02.ppt

#3 Who Keeps Savings from High Yield, Capital-intensive Re-engineering?

Focused on early supplier adopters and innovations with negative provider ROI

Purchaser (mostly)

Shared by purchaser& supplier

Page 6: Will Consumer-Driven Health Care Improve the Value of Health Insurance Benefits?

© 2002 Mercer Human Resource Consulting 6G:\HCGB\MAS\MILSTEIN\meetings\Health Policy cc 9-24-02.ppt

#4 Cost Insulation for Highest Risk Consumers

Out-of-pocket limits that exclude higher co-pay or co-insurance tiers

when more efficient, high quality options are available;

and/or positive incentives for highest risk consumers.

Unconditional Conditional

Page 7: Will Consumer-Driven Health Care Improve the Value of Health Insurance Benefits?

© 2002 Mercer Human Resource Consulting 7G:\HCGB\MAS\MILSTEIN\meetings\Health Policy cc 9-24-02.ppt

How Much Do Economic Pivot Points Matter?

Static Savings

Ungeared plan (PCA)

Positive incentives geared to consumer-selected provider,care management and tx option

Negative incentives geared to consumer-selected provider,care management and tx option

Dynamic Savings

If “critical mass” tips continuous supplier re-engineering

7%-8%

10%-15%

15%-25%

>30%

Consumer Engagement Approach Est. Premium Trend Offset

Page 8: Will Consumer-Driven Health Care Improve the Value of Health Insurance Benefits?

© 2002 Mercer Human Resource Consulting 8G:\HCGB\MAS\MILSTEIN\meetings\Health Policy cc 9-24-02.ppt

Beyond Economic Efficiency:Ingredients Critical to Improved 6-D Quality

Provider payment levels (including care management providers) determined by:

– Publicly reported standardized performance measures (NQF-endorsed) in 5 or 6 domains

– Performance excellence

Consumer decision-support

Increase AHRQ and FDA funding for performance reporting for major treatment options